Registration is $495 for professionals and $225 for government employees and students. Click here to register online for the 4th International PEEK Meeting.
Based on feedback from last year's meeting the organizers have elected not to reserve a meeting block because of the numerous hotels on Dupont Circle, near the conference venue.
The 4th International PEEK Meeting will be convened from April 25 to 26, 2019 in Washington, DC, USA at the Cosmos Club. The conference will be hosted by the Implant Research Center of Drexel University in collaboration with Exponent, Inc., with support provided by Invibio Biomaterial Solutions™.
The purpose of the conference is to bring together engineers, scientists, regulators, and clinicians from academia, industry, and government agencies for the presentation of leading edge research on advancements in medical grade polyaryletherketone (PAEK) polymer technology and clinical applications.
Although all scientific studies, clinical applications and innovations related to the broad family of medical grade PAEKs are welcomed at this conference the majority of submissions are expected to be related to implantable PEEK and its composites.
The first day of the conference will include focused sessions on regulatory aspects of PEEK medical devices, organized in collaboration with scientists from FDA.
The 4thInternational PEEK Meeting will focus on identifying and closing gaps in the regulatory science for medical grade PEEK technology and clinical applications including:
Steven Kurtz, Ph.D., Implant Research Center, Drexel University and Exponent, Inc. Joanne Tipper, Ph.D., University of Technology Sydney
Jeremy Gilbert, Ph.D., Clemson University
Katherine Kavlock, Ph.D., US FDA CDRH (Center for Devices and Radiological Health)
John Bowsher, Ph.D., US FDA CDRH
A wave of recent research projects presented at the latest International PEEK Meeting* in Washington, D.C., has highlighted the increasing adoption of PEEK implants in clinical practice as well as the material´s established position due to possible patient benefits.